Brizzi V - Search Results

1

Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol.

Brizzi A, Brizzi V, Valoti M. Brizzi A, et al. Among authors: brizzi v. Farmaco. 2005 Feb;60(2):105-11. doi: 10.1016/j.farmac.2004.11.003. Farmaco. 2005. PMID: 15752469

2

Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.

Brizzi A, Brizzi V, Cascio MG, Bisogno T, Sirianni R, Di Marzo V. Brizzi A, et al. Among authors: brizzi v. J Med Chem. 2005 Nov 17;48(23):7343-50. doi: 10.1021/jm0501533. J Med Chem. 2005. PMID: 16279794

3

Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors.

Brizzi A, Cascio MG, Brizzi V, Bisogno T, Dinatolo MT, Martinelli A, Tuccinardi T, Di Marzo V. Brizzi A, et al. Among authors: brizzi v. Bioorg Med Chem. 2007 Aug 15;15(16):5406-16. doi: 10.1016/j.bmc.2007.05.060. Epub 2007 May 31. Bioorg Med Chem. 2007. PMID: 17561406

4

New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo.

Brizzi A, Brizzi V, Cascio MG, Corelli F, Guida F, Ligresti A, Maione S, Martinelli A, Pasquini S, Tuccinardi T, Di Marzo V. Brizzi A, et al. Among authors: brizzi v. J Med Chem. 2009 Apr 23;52(8):2506-14. doi: 10.1021/jm8016255. J Med Chem. 2009. PMID: 19331413

5

The interactions of the 5-HT3 receptor with quipazine-like arylpiperazine ligands: the journey track at the end of the first decade of the third millennium.

Cappelli A, Butini S, Brizzi A, Gemma S, Valenti S, Giuliani G, Anzini M, Mennuni L, Campiani G, Brizzi V, Vomero S. Cappelli A, et al. Among authors: brizzi v, brizzi a. Curr Top Med Chem. 2010;10(5):504-26. doi: 10.2174/156802610791111560. Curr Top Med Chem. 2010. PMID: 20166948 Review.

6

Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.

Brizzi A, Aiello F, Marini P, Cascio MG, Corelli F, Brizzi V, De Petrocellis L, Ligresti A, Luongo L, Lamponi S, Maione S, Pertwee RG, Di Marzo V. Brizzi A, et al. Among authors: brizzi v. Bioorg Med Chem. 2014 Sep 1;22(17):4770-83. doi: 10.1016/j.bmc.2014.07.006. Epub 2014 Jul 12. Bioorg Med Chem. 2014. PMID: 25065940

7

Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor.

Brizzi A, Cascio MG, Frosini M, Ligresti A, Aiello F, Biotti I, Brizzi V, Pertwee RG, Corelli F, Di Marzo V. Brizzi A, et al. Among authors: brizzi v. J Med Chem. 2011 Dec 22;54(24):8278-88. doi: 10.1021/jm200529h. Epub 2011 Nov 16. J Med Chem. 2011. PMID: 22044209

8

New 1,2,4-oxadiazole derivatives: synthesis and adrenergic receptors binding studies.

Brizzi V, Brufani M, Filocamo L, Bruni G, Fiaschi AI. Brizzi V, et al. Farmaco. 1992 Jun;47(6):953-66. Farmaco. 1992. PMID: 1326978

9

Synthesis, binding affinity and selectivity of new beta 1- and beta 2-adrenoceptor blockers.

Brizzi V, Francioli M, Brufani M, Filocamo L, Bruni G, Massarelli P. Brizzi V, et al. Farmaco. 1999 Nov-Dec;54(11-12):713-20. doi: 10.1016/s0014-827x(99)00077-4. Farmaco. 1999. PMID: 10668169

10

Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors.

Bonechi C, Martini S, Brizzi V, Brizzi A, Massarelli P, Bruni G, Rossi C. Bonechi C, et al. Among authors: brizzi v, brizzi a. Eur J Med Chem. 2006 Oct;41(10):1117-23. doi: 10.1016/j.ejmech.2006.05.017. Epub 2006 Jul 11. Eur J Med Chem. 2006. PMID: 16837109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters